NatRevCardiol Profile Banner
Nature Reviews Cardiology Profile
Nature Reviews Cardiology

@NatRevCardiol

Followers
21K
Following
403
Media
996
Statuses
4K

Official account of Nature Reviews Cardiology, publishing high-quality Reviews, news and opinion articles on cardiovascular research and clinical cardiology

London
Joined November 2011
Don't wanna be here? Send us removal request.
@NatRevCardiol
Nature Reviews Cardiology
5 years
Finding it hard to navigate the flood of scientific literature? The Nature Reviews journals filter and highlight the most impactful research. Take a look at this animation to learn how Nature Reviews can help you to stay up-to-date in your field
8
8
25
@NatRevCardiol
Nature Reviews Cardiology
7 days
New online! An ex vivo perfusion platform for the testing of cardiovascular interventional devices https://t.co/E1oj7eo547
1
1
8
@NatRevCardiol
Nature Reviews Cardiology
8 days
New online! Anticoagulation in patients with rheumatic heart disease and atrial fibrillation: implications for low-resource regions
nature.com
Nature Reviews Cardiology - Sura Markos discusses the findings from the INVICTUS trial and the implications for anticoagulation strategies in patients with rheumatic atrial fibrillation,...
0
2
9
@fund_defi
DeFi Education Fund
4 days
1/ Citadel got DeFi wrong. Today, DEF, @a16z, @DigitalChamber, @orca_so, @theblockprof, & @UniswapFND wrote to @SECGov in response to @citsecurities' letter misrepresenting how DeFi technology works. Why this group? Citadel blatantly miscited us, and we feel obligated to
41
83
296
@NatRevCardiol
Nature Reviews Cardiology
21 days
New online! Redefining heart failure subtypes according to skeletal muscle mass https://t.co/zHXNpxpgDW
2
108
336
@NatRevCardiol
Nature Reviews Cardiology
2 months
New online! Safely implementing new knowledge from trials of withholding β-blockers after myocardial infarction
Tweet card summary image
nature.com
Nature Reviews Cardiology - New evidence from five randomized trials suggests that withholding β-blockers after myocardial infarction (MI) is safe for carefully selected, low-risk patients....
0
1
2
@NatRevCardiol
Nature Reviews Cardiology
2 months
New online! Cardiovascular disease prevention in China: challenges and opportunities in the artificial intelligence-enabled digital health era https://t.co/hsiQOnOaY0
0
0
0
@NatRevCardiol
Nature Reviews Cardiology
2 months
New online! AQUATIC findings sink antiplatelet therapy for patients with chronic coronary syndrome requiring oral anticoagulants
Tweet card summary image
nature.com
Nature Reviews Cardiology - In patients with chronic coronary syndrome and an indication for oral anticoagulation, whether continuation of antiplatelet therapy in the initial phase after...
1
0
3
@NatRevCardiol
Nature Reviews Cardiology
2 months
New online! LOX1 blockade does not modify atherosclerosis progression in patients with MI
0
0
1
@NatRevCardiol
Nature Reviews Cardiology
2 months
New online! The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges https://t.co/nj3hdwjLF4
0
2
4
@NatRevCardiol
Nature Reviews Cardiology
3 months
New online! Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system https://t.co/M9u6Le3orW
0
5
7
@DaveBondyTV
Dave Bondy
2 months
Nationwide Push-to-Talk Radios. Keep Your Family Safe Anywhere. Instant Communication for Work & Home
0
34
264